You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
尚榮醫療(002551.SZ):實控人及其關聯人合計持股變動比例為7.3296%
格隆匯 03-03 19:58

格隆匯3月3日丨尚榮醫療(002551.SZ)公佈,公司近日收到公司控股股東、實際控制人樑桂秋及其關聯人樑桂添、樑桂忠、黃寧、樑俊華、樑桂花、樑桂歡、陳建忠及張洪發出具的簡式權益變動報告書。樑桂秋為公司控股股東、實際控制人,黃寧為樑桂秋的配偶,樑桂添、樑桂忠為樑桂秋的弟弟,樑桂花、樑桂歡為樑桂秋的妹妹,樑俊華為樑桂秋之子,陳建忠、張洪發為樑桂秋的妹夫,因此,上述九人屬於《上市公司收購管理辦法》規定的一致行動人。

此次權益變動涉及:1、因信息披露義務人為降低股份質押風險,信息披露義務人樑桂秋及其關聯人樑俊華以集中競價交易方式和大宗交易方式減持其持有的部分公司股份,從而導致樑桂秋及其關聯人持股變動比例為1.2765%;2、因公司可轉換公司債券轉股公司總股本增加造成信息披露義務人的股份被動減持的持股變動比例為6.0531%,信息披露義務人合計持股變動比例為7.3296%。

次權益變動後,公司控股股東、實際控制人樑桂秋持股比例33.5704%樑桂秋與一致行動人樑桂添、樑桂忠、黃寧、樑俊華、樑桂花、樑桂歡、陳建忠及張洪發合計持股比例42.9224%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account